LakeShore Biopharma Co. Ltd (LSB) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

LakeShore Biopharma Co. L... (LSB)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

2.75

-0.13 (-4.51%)

At close: Jan 14, 2025, 3:22 PM

2.75

0.00%

After-hours Jan 14, 2025, 03:23 PM EST

undefined% (undefined)

Bid	2.58
Market Cap	52.47M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-2.81
PE Ratio (ttm)	-0.98
Forward PE	n/a
Analyst	n/a

Ask	3.58
Volume	12,498
Avg. Volume (20D)	43,395
Open	2.87
Previous Close	2.88
Day's Range	2.58 - 2.92
52-Week Range	1.88 - 11.20
Beta	undefined

About LSB

LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the Uni...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Aug 5, 2021

Employees 758

Stock Exchange NASDAQ

Ticker Symbol LSB

Website https://www.ysbiopharm.com

Next Earnings Release

LakeShore Biopharma Co. Ltd is scheduled to release its earnings on Jan 21, 2025, after market closes.
Analysts project revenue of $25.05M, reflecting a 27.83% YoY growth and earnings per share of -0.97, making a -3.00% decrease YoY.

Why Price Moved

3 months ago · Source

+21.15%

LakeShore Biopharma shares are trading higher afte... Unlock content with Pro Subscription

5 months ago · Source

+2.5%

LakeShore Biopharma shares are trading higher. The company reported FY24 financial results.

News

1 month ago · businesswire.com

LSB Industries Announces Publication of 2023 Sustainability Report

OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (“LSB” or “the Company”), (NYSE: LXU) today announced the publication of its 2023 Sustainability Report, highlighting the Company's progress in adv...

2 months ago · businesswire.com

LSB Industries, Inc. Appoints John Chandler as an Independent Member of the Board of Directors

OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (“LSB” or “the Company”), (NYSE: LXU) today announced that it has appointed John Chandler as an independent member of the Board of Directors (the “...

2 months ago · businesswire.com

LSB Industries, Inc. Reports Operating Results for the 2024 Third Quarter

OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (NYSE: LXU) (“LSB” or the “Company”) today announced results for the third quarter ended September 30, 2024. Third Quarter 2024 Results and Recent ...